Jvermectina como um inibidor das Ca2*-ATPases de membrana plasmática e de retículo sarco/endoplasmático no ducto deferente de rato

Authors

  • Humberto Muzi-Filho Universidade Federal do Rio de Janeiro
  • Dominick Rodrigues Alves de Souza Universidade Federal do Rio de Janeiro
  • Christianne Bretas Vieira Scaramello Universidade Federal Fluminense
  • Valeria do Monti Nascimento Cunha Universidade Federal do Rio de Janeiro

DOI:

https://doi.org/10.24220/2318-0897v23n2a2526

Keywords:

Calcium, Ivermectin, Rats

Abstract

Objective

The present work investigated the effect of ivermectin on Ca2+ content and on the Ca2+-ATPase activity (represented by the plasma membrane Ca2+-ATPase and the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase present in rat vas deferens.

Methods

The assays were carried out using ultracentrifuged homogenate preparations from rat vas deferens in the presence or absence of the 12-kDa FK506-binding protein-Ca2+ release channel complex. Measures of Ca2+ content and Ca2+ ATPase activity were then carried out in function of different concentrations of ivermectin.

Results

The data show that ivermectin (10 μM) reduces the sarcoplasmic reticulum Ca2+ content in FK506-binding protein (+) and FK506-binding protein (-) fractions of ultracentrifuged homogenate from rat vas deferens (inhibition of 50% and 40%, respectively, p<0.05) and inhibits both the activities of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase and plasma membrane Ca2+-ATPases pumps (33% and 16%, respectively, p<0.05).

Conclusion

These data suggest that ivermectin effects Ca2+ handling in the rat vas deferens, indicating that this drug could alter the contractility of this smooth muscle. Therefore, ivermectin could be an interesting pharmacological tool to alter the physiological function of vas deferens and to manipulate the fertility status of male rats.

 

Downloads

Download data is not yet available.

Author Biographies

Humberto Muzi-Filho, Universidade Federal do Rio de Janeiro

1 Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Instituto de Ciências Biomédicas, Programa de Pós-Graduação em Farmacologia e Inflamação. Av. Carlos Chagas Filho, 373, Cidade Universitária, 21941-902, Rio de Janeiro, RJ, Brasil. Correspondência para/Correspondence to: H MUZI-FILHO. E-mail: <hmuzifilho@yahoo.com.br>.
2 Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Instituto de Biofísica Carlos Chagas Filho, Programa de Pós-
Graduação em Fisiologia e Biofísica Celular. Rio de Janeiro, RJ, Brasil.
3 Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Instituto Nacional de Ciências e Tecnologia de Biologia Estrutural e Bioimagem. Rio de Janeiro, RJ, Brasil.

Dominick Rodrigues Alves de Souza, Universidade Federal do Rio de Janeiro

1 Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Instituto de Ciências Biomédicas, Programa de Pós-Graduação
em Farmacologia e Inflamação. Av. Carlos Chagas Filho, 373, Cidade Universitária, 21941-902, Rio de Janeiro, RJ, Brasil.

Christianne Bretas Vieira Scaramello, Universidade Federal Fluminense

4 Universidade Federal Fluminense, Instituto Biomédico, Departamento de Fisiologia e Farmacologia. Niterói, RJ, Brasil.

Valeria do Monti Nascimento Cunha, Universidade Federal do Rio de Janeiro

1 Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Instituto de Ciências Biomédicas, Programa de Pós-Graduação
em Farmacologia e Inflamação. Av. Carlos Chagas Filho, 373, Cidade Universitária, 21941-902, Rio de Janeiro, RJ, Brasil.

References

Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, et al. -Adrenoceptors are required for normal male sexual fuction. Br J Pharmacol. 2007; 152(3):332-40.

Lepor H. The emerging role of alpha antagonists in the therapy of benign prostatic hyperplasia. J Androl. 1991; 12(6):389-94.

Tambaro S, Ruiu S, Dessi C, Mongeau R, Marchese G, Pani L. Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: Relevance to ejaculation delays.

J Pharmacol Exp Ther. 2005; 312(2):710-17.

van Dijk MM, de la Rosette JJMCH, Michel MC. Effects of -adrenoceptor antagonists on male sexual function. Drugs. 2006; 66(3):287-301.

Mulryan K, Gitterman DP, Lewis, CJ, Vial C, Leckle BJ, Cobb AL, et al. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature. 2000; 403(6765):86-9.

Muzi-Filho H, Bezerra CGP, Souza AM, Boldrini LC, Takiya CM, Oliveira FL, et al. Undernutrition affects cell survival, oxidative stress, Ca2+ handling and signaling pathways in vas deferens, crippling reproductive capacity. PLOS ONE. 2013; 26(8):e69682.

Marín J. Mechanisms involved in the increased vascular resistance hypertension. J Auton Pharmacol. 1993; 13(2):127-76.

Kuriyama H, Kitamura K, Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev. 1995; 47(3):387-573.

Orallo F. Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol Ther. 1996; 69(3):153-71.

Iino M. Dynamic regulation of intracellular calcium signal through calcium release channels. Mol Cell Biochem. 1999; 190(1-2):185-90.

Rodriguez JB, Muzi-Filho H, Valverde RH, Quintas LE, Noel F, Einicker-Lamas M, et al. Rat vas deferens SERCA2 is modulated by Ca2+/calmodulin protein kinase II-mediated phosphorylation. Braz J Med Biol Res. 2013; 46(3):227-34.

Scaramello CBV, Muzi-Filho H, Zapata-Sudo G, Sudo RT, Cunha VMN. FKBP12 depletion leads to loss of sarcoplasmic reticulum Ca2+ stores in rat vas deferens. J Pharmacol Sci. 2009; 109(2):185-92.

Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci. 1995; 92(5):1784-788.

Campbell WC. Ivermectin as an antiparasitic agent for use in humans. Annu Rev Microbiol. 1991; 45:445-74.

Liu LX, Weller PF. Antiparasitic drugs. N Engl J Med. 1996; 334(18):1178-84.

Ahern GP, Junankar PR, Pace SM, Curtis S, Mould JA, Dulhunty A. Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle. J Physiol. 1999; 514(Pt 2):313-26.

Bilmen JG, Wootton LL, Michelangeli F. The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+- ATPase by macrocyclic lactones and cyclosporin A. Biochem J. 2002; 366(Pt 1):255-63.

Scaramello CBV, Cunha VMN, Rodriguez JBR, Noel F. Characterization of subcellular fractions and distribution profiles of transport components involved in Ca2+ homeostasis in rat vas deferens. J Pharmacol Toxicol Methods. 2002; 47(2):93-8.

Spencer GG, Yu X, Khan I, Grover AK. Expression of isoforms of internal Ca2+ pump in cardiac, smooth muscle and non-muscle tissues. Biochim Biophys Acta. 1991; 1063(1):15-20.

Carmody M, Mackrill JJ, Sorrentino V, O’Neill C. FKBP12 associates tightly with the skeletal muscle type 1 ryanodine receptor, but not with other intracellular calcium release channels. FEBS Lett. 2001; 505(1):97-102.

Mackrill JJ, O’Driscoll S, Lai FA, McCarthy TV. Analysis of type 1 ryanodine receptor-12 kDa FK506-binding protein interaction. Biochem Biophys Res Commun. 2001; 285(1):52-7.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Follin phenol reagent. J Biol Chem. 1951; 193(1):265-75.

Fabiato A, Fabiato F. Calculator programs for computing the composition of the solutions containing multiple metal and ligands used for experiments in skinned muscle cells. J Physiol. 1979; 75(5):463-505.

Christensen SB, Larsen IK, Rasmussen U. Thapsigargin and thapsigargicin, two histamine liberating sesquiterpene lactones from Thapsia garganica. Xray analysis of the 7,11-epoxide of thapsigargin. J Org Chem. 1982; 47(4):649-52.

Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci. 1990; 87(7):2466-70.

Inesi G, Sagara Y. Specific inhibitors of intracellular Ca2+ transport ATPases. J Membr Biol. 1994; 141(1):1-6.

Grubmeyer C, Penefsky MS. The presence of two hydrolytic sites on beef heart mitochondrial adenosine triphosphatase. J Biol Chem. 1981; 256(8):3718-27.

Marín J, Encabo A, Briones A, García-Cohen EC, Alonso MJ. Mechanisms involved in the cellular calcium homeostasis in vascular smooth muscle: Calcium pumps. Life Sci. 1999; 64(5):279-303.

Wootton LL, Argent CCH, Wheatley M, Michelangeli F. The expression, activity and localisation of the secretory pathway Ca2+-ATPase (SPCA1) in different mammalian tissues. Biochim Biophys Acta. 2004; 1664(2):189-97.

Published

2014-08-31

How to Cite

Muzi-Filho, H., Souza, D. R. A. de, Scaramello, C. B. V., & Cunha, V. do M. N. (2014). Jvermectina como um inibidor das Ca2*-ATPases de membrana plasmática e de retículo sarco/endoplasmático no ducto deferente de rato. Revista De Ciências Médicas, 23(2), 75–82. https://doi.org/10.24220/2318-0897v23n2a2526

Issue

Section

Artigos Originais